Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2025-03-04 Regulatory Filings
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by the company Pangen. It details the contract value, counterparty, duration, and payment terms. Since this is a specific regulatory announcement of a business contract that does not fit into categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2025-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Pangen) announcing a significant change (over 30%) in revenue or profit structure. This is a standard 'Earnings Release' (ER) format used in the Korean market to provide preliminary financial results before the final audited report is published. It includes key financial metrics, reasons for the change, and a disclaimer that it is based on unaudited figures. FY 2024
2025-02-03 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is an official regulatory filing from a Korean company (Pangen) regarding the 'Adjustment of Conversion Price' for convertible bonds. This type of filing details changes to the capital structure and conversion terms of debt instruments. According to the provided definitions, this falls under 'Capital/Financing Update' (CAP), as it relates to financing activities and adjustments to the terms of issued securities.
2024-12-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors or major shareholders to disclose their shareholdings and changes therein. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and changes in ownership by company directors and executives.
2024-12-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details a change in shareholding (an increase) by a major shareholder, Huons Co., Ltd., in the company Pangen. This type of filing is specifically designed to report changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' category.
2024-12-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a mandatory regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including the identity of the major shareholder, the number of shares held, and the purpose of the holding (e.g., influencing management). This falls under the category of Major Shareholding Notification.
2024-12-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.